Humana’s CenterWell Expands Specialty Pharmacy As GLP-1 Drugs Take Off
Humana’s CenterWell will begin filling and shipping orders for the GLP-1 weight loss drug Wegovy that are prescribed through Hims & Hers Health, LifeMD and Ro.
Apr 29
GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice
Nature Metabolism, Published online: 29 April 2025; doi:10.1038/s42255-025-01294-x This study, together with a companion manuscript, show that, in mice, weight loss as a result of GIP receptor antagonism requires, and potentiates, functional GLP-1 receptor signalling in the brain, explaining how both GIP receptor agonists and antagonists trigger weight loss through different mechanisms.
Journal Article – “Body Composition Metrics as a Determinant of Trastuzumab Deruxtecan Related Toxicity and Response”
Yaacobi Peretz, S., Kessner, R., Bar, Y. et al. Body composition metrics as a determinant of trastuzumab deruxtecan related toxicity and response. npj Breast Cancer 11, 38 (2025). https://doi.org/10.1038/s41523-025-00754-7 This scientific article explores the connection between a patient’s body composition and their experience with the drug trastuzumab deruxtecan (T-DXd) for metastatic breast cancer. Using computed tomography scans to measure muscle and … Read more
Hims and Novo Nordisk partner to offer discounted Wegovy
In an unlikely partnership between two rivals, Hims & Hers said its members will now be able to get Novo Nordisk’s weight loss drug Wegovy at a discounted price directly through the telehealth platform. …
STAT+: The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position
The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options. Blockbuster obesity and diabetes drugs — such as Wegovy, Ozempic, and Mounjaro — are no longer deemed by regulators to be in shortage, so compounding pharmacies and the telehealth companies … Read more
Do GLP-1 Drugs Pose a Risk to Lung Transplant Recipients?
(MedPage Today) — People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a small, single-center cohort study suggested. In a retrospective review of 301 consecutive lung transplants…
Gen Z Is Leading a New Weight Loss Trend: Ozempic Microdosing
Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.
There’s a New Rapid Weight Loss Trend in Time for Summer: Skin Patches
Summer is approaching, and social media has been filled with reminders of its impending arrival. This year, there’s a clear revival of early 2000s trends, from outfits featuring Y2K hats and minimalistic tops to an increased focus on slim body types. The body positivity discourse seems to have dwindled, giving way to a renewed obsession … Read more